Suntrust Banks’s XBiotech XBIT Stock Holding History

Suntrust Banks’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,353	Closed	-$213K	–	1358
2019 Q1	$213K	Buy	+19,353	New	+$157K	﹤0.01%	1217

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Suntrust Banks's XBIT Position: Q2 2019 in Review

Suntrust Banks sold out of XBiotech (XBIT) in Q2 2019, closing a stake of 19,353 shares — an estimated $213K sold.

Suntrust Banks first reported a position in XBIT in Q1 2019 and held it in 1 quarter. The position peaked at $213K in Q1 2019. 43 funds tracked by Wall St. Rank hold XBIT as of Q2 2019.

Suntrust Banks reported no remaining XBiotech position as of Q2 2019 after selling out during the quarter.
Suntrust Banks sold 19,353 XBiotech shares in Q2 2019, an estimated $213K.
Suntrust Banks first reported a position in XBiotech in Q1 2019 and held it in 1 quarter.
Suntrust Banks's XBiotech position peaked at $213K in Q1 2019.
43 funds tracked by Wall St. Rank held XBiotech as of Q2 2019.

Based on Suntrust Banks's 13F filing for Q2 2019, filed 6 Aug 2019.